Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care. Roberts A, Hallet J, Nguyen L, Coburn N, et al. Breast Cancer Res Treat 2024 Apr 27. doi: 10.1007/s10549-024-07282.

Read + Share

Amedeo Smart

Independent Medical Education

Roberts A, Hallet J, Nguyen L, Coburn N, et al. Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care. Breast Cancer Res Treat 2024 Apr 27. doi: 10.1007/s10549-024-07282.
PMID: 38676808